Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yi Xiang

3PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 27, 2026

Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial.

|Jan 20, 2025

EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF<sup>V600E</sup> mutation: a multi-center real-world experience in China.

Wenyue Yang, Xiangran Feng, Jian Ni

|Mar 07, 2018

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients.

Zhe Yang, Nong Yang, Qiuxiang Ou

Pageof 1

Frequent Collaborators

1 joint publications

Xue Wu

1 joint publications

Wenyue Yang

1 joint publications

Xiangran Feng

1 joint publications

Xin Zhang

1 joint publications

Jialei Wang

1 joint publications

Wei-Xiang Qi

1 joint publications

Mengdi Wang

1 joint publications

Gang Cai

1 joint publications

Jiayi Chen

1 joint publications

Shengguang Zhao

Frequent Collaborators

1 joint publications

Xue Wu

1 joint publications

Wenyue Yang

1 joint publications

Xiangran Feng

1 joint publications

Xin Zhang